Navigation Links
Organovo To List Common Stock On New York Stock Exchange MKT
Date:7/9/2013

dditional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including our transition report on Form 10-KT filed with the SEC on May 24, 2013.  You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
2. Organovo, Inc. to Webcast, Live, at RetailInvestorConferences.com on March 1st
3. Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
4. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
5. Organovo Announces Relocation and Commencement of Operations at Larger Facility
6. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
7. Organovo To Present At Lazard Healthcare Conference
8. Organovo Reports Q3 2012 Financial Results, Provides Business Update
9. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Organovo Partners With ZenBio to Create 3D Tissue Models
11. Organovo to Present at the 12th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 Erlab , the ... since 1968 and Burdinola, supplier of laboratory furniture solutions, ... filtered fume hood. , By integrating ... Burdinola will now offer an innovative solution utilizing the ... of chemicals, best-in-class detection technology, and communication for security ...
(Date:9/23/2014)... 23, 2014 For the fifth time since ... list of the fastest-growing companies. , “We’re so proud ... again by Inc. Magazine,” ExakTime CEO Tony Pappas said. , ... posting a three-year growth rate of 61 percent from 2010 ... by more than 40 percent. , Pappas cited strong performance ...
(Date:9/23/2014)... 23, 2014  Age Defying Dermatology ® , owned ... become one of the first clinics in the Bay ... laser for tattoo removal. The treatment safely and effectively ... years, tattoo removal has been a lengthy, painful, and ... is an opportunity to erase tattoo pigment more efficiently ...
(Date:9/23/2014)... Cambridge Semantics, the leading provider of Smart Data ... the recent ‘Hype Cycle for Life Sciences 2014 ’ ... key insights pertaining to the benefits in the knowledge ... Shanler and Stephen Davies, “The use of these systems ... scientific stakeholders, and support collaboration and innovation strategies as ...
Breaking Biology Technology:Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ExakTime Makes Inc. 5000 List for the Fifth Time 2Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2
... Aug. 20 Vical Incorporated,(Nasdaq: VICL ) ... with,the appointment of Andrew R. de Guttadauro as ... Mr. de Guttadauro was Senior Director of,Strategy at ... overseeing the commercial development of that company,s Zevalin,the ...
... with Sales Team Forming and Increased Space, Poised for ... Medical Technologies,Inc., which is developing innovative devices for the ... a VP of Sales, Joseph W.,Rafferty, and has started ... its first product, Pathway PV(TM) Atherectomy System. Recently ...
... and CLAREMONT, Calif., Aug. 14 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products ... the second quarter of 2007 increased more than,35% over ... 139 times,revenues of just $13,351 for the same period ... half of 2007 were $3,256,000 compared to only,$24,374 in ...
Cached Biology Technology:Vical Names Andrew de Guttadauro Vice President, Corporate Development 2Vical Names Andrew de Guttadauro Vice President, Corporate Development 3Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth 2Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 2Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 3Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 4Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 5Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 6
(Date:9/22/2014)... ATLANTA September 23, 2014 A new American ... Supplemental Nutrition Assistance Program (SNAP), previously known as ... scores compared with income eligible non-participants. The authors ... programs aimed at enhancing the dietary quality of ... assist low-income individuals and households with the resources ...
(Date:9/22/2014)... Yale University researchers are studying a potential new ... respiratory disease in which scars develop in the lungs ... microRNA mimic, miR-29, which is delivered to lung tissue ... fibrosis, it reversed fibrosis after several days. , ... EMBO Molecular Medicine . , "The mimic, when ...
(Date:9/22/2014)... sequencing technologies continue to evolve rapidly, becoming part of ... appropriate policies and regulatory frameworks to address potential challenges, ... issue of the Journal of Law, Medicine & ... with the Center for Medical Ethics and Health Policy ... tools to jumpstart this process. , Experts with ...
Breaking Biology News(10 mins):Federal food program puts food on the table, but dietary quality could be improved 2Reversing the effects of pulmonary fibrosis 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3
... an Israeli start-up company, launched its first "solar farm" near ... systems developed by Prof. David Faiman of Ben-Gurion University ... Faiman, who is chairman of the Department of ... for Desert Research, believes the new system will harvest more ...
... for the 61st Annual Meeting of the Rocky Mountain ... 11-13 May 2009 in Orem, Utah. Utah Valley ... library building on the UVU campus. Brigham Young University ... and industry scientists, and graduate and undergraduate students, will ...
... Ill. Researchers at the University of Illinois have ... one or more molecules into the cytoplasm or the ... amounts of cargo, the nanoneedle can also be used ... "Nanoneedle-based delivery is a powerful new tool for studying ...
Cached Biology News:Ben-Gurion University research and technology used in new solar energy farm 2Geoscientists meet to discuss Rocky Mountain geology 2Nanoneedle is small in size, but huge in applications 2
BioGenex IHC Kits for Rodent Tissues are designed for immunohistochemistry on rodent and rabbit tissues that are closely related to the source of the primary antibody. This kit comes with rat seconda...
... is available in a ready-to-use format. ... for dewaxing paraffin-embedded tissue sections prior ... or other analytical methods. The conventional ... dipping the slides in a series ...
... The BioGenex Super ... System is a novel ... proprietary non-biotin polymeric technology. ... high signal to noise ...
... thermal cycler is a compact instrument for gene ... tubes, 12 x 0.5 ml tubes, or a ... a thumbwheel to adjust height and pressure to ... heat pumps provide excellent thermal performance, and the ...
Biology Products: